A - Human Necessities – 61 – L
Patent
A - Human Necessities
61
L
A61L 31/16 (2006.01) A61L 31/00 (2006.01)
Patent
CA 2677646
A method of improving the resistance of collagenous tissue subject to elevated collagenous tissue stress as a result of tissue removing surgical decompression surgery, comprising contacting at least a portion of the remaining collagenous tissue with an effective amount of a crossl inking reagent.
Procédé permettant d'améliorer la résistance d'un tissu collagène soumis à une contrainte élevée après une décompression chirurgicale par ablation de tissu, comprenant l'étape consistant à mettre au moins une partie du tissu collagène restant en contact avec une quantité efficace d'un réactif de réticulation.
Orthopeutics L.p.
Oyen Wiggs Green & Mutala Llp
LandOfFree
Direct application of non-toxic crosslinking reagents to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Direct application of non-toxic crosslinking reagents to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct application of non-toxic crosslinking reagents to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1626839